Electrochemistry of raloxifene on glassy carbon electrode and its determination in pharmaceutical formulations and human plasma

Bioelectrochemistry

Volumn 88, Issue , 2012, Pages 164-170

  Bagheri, Akbar ^a   Hosseini, Hadi ^a  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Glassy carbon electrode; Pharmaceutical formulations; Plasma samples; Raloxifene; Voltammetry

Indexed keywords

ANODIC PEAKS; DETECTION LIMITS; DIFFERENTIAL PULSE VOLTAMMETRY; ELECTROCHEMICAL BEHAVIORS; ELECTROCHEMICAL REACTIONS; GLASSY CARBON ELECTRODES; HUMAN PLASMA SAMPLES; HUMAN PLASMAS; OPTIMUM CONDITIONS; PHARMACEUTICAL FORMULATION; PLASMA SAMPLES; QUANTITATIVE DETERMINATIONS; QUASI-REVERSIBLE PROCESS; RALOXIFENE; REDOX MECHANISM; RELATIVE STANDARD DEVIATIONS; SCAN RATES; SUPPORTING ELECTROLYTE;

ADSORPTION; CYCLIC VOLTAMMETRY; PLASMA (HUMAN); VOLTAMMETRY;

GLASS MEMBRANE ELECTRODES;

CARBON; ELECTROLYTE; RALOXIFENE;

ARTICLE; BLOOD ANALYSIS; CYCLIC POTENTIOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG DETERMINATION; DRUG FORMULATION; ELECTROCHEMISTRY; ELECTRODE; HUMAN; OXIDATION REDUCTION REACTION; PH; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

BLOOD CHEMICAL ANALYSIS; CARBON; CHEMISTRY, PHARMACEUTICAL; ELECTROCHEMISTRY; ELECTRODES; GLASS; HUMANS; LIMIT OF DETECTION; RALOXIFENE; TIME FACTORS;

EID: 84866529261     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2012.03.007     Document Type: Article

References (46)

1. Smith A., Heckelman P.E., Obenchain J.R., Gallipeau J.A.R., Arecca M.A.D., Budavari S. The Merck Index 2001, Whitehouse Station. 13th Ed.
2. Reginster J.Y., Devogelaer J.P. Raloxifene reduces fractures in postmenopausal women with osteoporosis. Clin. Orthop. Relat. Res. 2006, 443:48-54.
3. Delmas P.D., Ensrud K.E., Adachi J.D., Harper K.D., Sarkar S., Gennari C., Reginster J.Y., Pols H.A., Recker R.R., Harris S.T., Wu W., Genant H.K., Black D.M., Eastell R. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J. Clin. Endoc. Meta. 2002, 87:3609-3617.
4. Barrett-Connor E., Mosca L., Collins P., et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N. Engl. J. Med. 2006, 355:125-137.
5. Stefanick M.L. Risk-benefit profiles of raloxifene for women. N. Engl. J. Med. 2006, 355:190-192.
6. Hardman J.G., Limbird L.E., Gilman A.G. Goodman & Gilman's the Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York. 10th Ed.
7. Kumar U.R.A., Basavaiah K., Tharpa K., Vinay K.B. Determination of raloxifene hydrochloride in human urine by LC-MS-MS. Chem. Ind. Chem. Eng. Quart. 2009, 15:119-123.
8. Trontelj J., Bogataj M., Marc J., Mrhar A. Development and validation of a liquid chromatography-tandem mass spectrometry assay for determination of raloxifene and its metabolites in human plasma. J. Chromatogr. B 2007, 855:220-227.
9. Zweigenbaum J., Henion J. Bioanalytical high-throughput selected reaction monitoring-LC/MS determination of selected estrogen receptor modulators in human plasma: 2000samples/day. Anal. Chem. 2000, 72:2446-2454.
10. Basavaiah K., Kumar U.R.A., Tharpa K. Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control. Acta. Pharm. 2008, 58:347-356.
11. Yang Z., He X., Zhang Y. The determination of raloxifene in rat tissue using HPLC. Biomed. Chromatogr. 2007, 21:229-233.
12. Yang Z.Y., Zhang Z.F., He X.B., Zhao G.Y., Zhang Y.Q. Validation of a novel HPLC method for the determination of raloxifene and its pharmacokinetics in rat plasma. Chromatographia 2007, 65:197-201.
13. Trontelj J., Vovk T., Bogataj M., Mrhar A. HPLC analysis of raloxifene hydrochloride and its application to drug quality control studies. Pharm. Res. 2005, 52:334-339.
14. Ruiz T.P., Lozano C.M., Sanz A., Bravo E. Development and validation of a quantitative assay for raloxifene by capillary electrophoresis. J. Pharm. Biomed. Anal. 2004, 34:891-897.
15. Kalyanaramu B., Raghubabu K. A quantitative assay for raloxifene hydrochloride in bulk and pharmaceutical preparations by visible spectrophotometry. J. Chem. Pharm. Res. 2011, 3:122-127.
16. Liu S.P., He Y.Q., Liu Z.F., Qun Min Lu L.K. Resonance Rayleigh scattering spectral method for the determination of raloxifene using gold nanoparticle as a probe. Anal. Chim. Acta 2007, 598:304-311.
17. Tsai T.H., Thiagarajan S., Chen S.M. Detection of melamine in milk powder and human urine. J. Agric. Food Chem. 2010, 58:4537-4544.
18. Ghorbani-Bidkorbeh F., Shahrokhian S., Mohammadi A., Dinarvand R. Simultaneous voltammetric determination of tramadol and acetaminophen using carbon nanoparticles modified glassy carbon electrode. Electrochim. Acta 2010, 55:2752-2759.
19. Hegde N.R., Kumara Swamy B.E., Shetti N.P., Nandibewoor S.T. Electro-oxidation and determination of gabapentin at gold electrode. J. Electroanal. Chem. 2009, 635:51-57.
20. Nigovic B., Simunic B., Hocevar S. Voltammetric measurements of aminosalicylate drugs using bismuth film electrode. Electrochim. Acta 2009, 54:5678-5683.
21. Wang L., Zhang Z., Ye B. Study on the electrochemical behaviour of the anticancer herbal drug emodin. Electrochim. Acta 2006, 51:5961-5965.
22. Uslu B., Dogan B., Ozkan S.A. Electrochemical studies of ganciclovir at glassy carbon electrodes and its direct determination in serum and pharmaceutics by square wave and differential pulse voltammetry. Anal. Chim. Acta 2005, 537:307-313.
23. Kim H.J., Kwak J. Electrochemical determination of total alkaline phosphatase in human blood with a micropatterned ITO film. J. Electroanal. Chem. 2005, 577:243-248.
24. Maleki N., Safavi A., Shahbaazi H.R. Electrochemical determination of 2,4-D at a mercury electrode. Anal. Chim. Acta 2005, 530:69-74.
25. Uslu B., Ozkan S.A. Electrochemical characterisation of nefazodone hydrochloride and voltammetric determination of the drug in pharmaceuticals and human serum. Anal. Chim. Acta 2002, 462:49-57.
26. Ghoneim E.M., El-Desoky H.S. Electrochemical determination of methocarbamol on a montmorillonite-Ca modified carbon paste electrode in formulation and human blood. Bioelectrochem. 2010, 79:241-247.
27. Belal F., Abdinic H., Zoman N. Voltammetric determination of nilvadipine in dosage forms and spiked human urine. J. Pharm. Biomed. Anal. 2001, 26:585-592.
28. Zuman P. Current status of polarography and voltammetry in analytical chemistry. Anal. Lett. 2000, 33:163-174.
29. Demircigil T., Ozkan S.A., Coruh O., Ilmaz S. Electrochemical behavior of formoterol fumarate and its determination in capsules for inhalation and human serum using differential-pulse and square-wave voltammetry. Electroanalysis 2002, 14:122-127.
30. Kalanur S.S., Seetharamappa J. Multi-walled carbon nanotube modified glassy carbon electrode as a sensor for the determination of raloxifene hydrochloride. Sens. Lett. 2011, 9:1403-1409.
31. Rezaei B., Damiri S. Fabrication of a nanostructure thin film on the gold electrode using continuous pulsed-potential technique and its application for the electrocatalytic determination of metronidazole. Electrochim. Acta 2010, 55:1801-1808.
32. Varmaghani F., Nematollahi D. Electrochemical study of 1,2-dihydropyridazine-3,6-dione in protic and aprotic solvents: oxidative ring cleavage and reduction. Electrochim. Acta 2011, 56:6089-6096.
33. Nematollahi D., Ghorbani A. Electrochemically induced Diels-Alder reaction of p-benzoquinone with 1,3-cyclopentadiene. J. Electroanal. Chem. 2008, 624:310-314.
34. Rafiee M., Nematollahi D. Electrochemical oxidation of catechols in the presence of cyanoacetone and methyl cyanoacetate. J. Electroanal. Chem. 2009, 626:36-41.
35. Nematollahi D., Tammari E., Esmaili R. Investigation of electrochemically induced conjugate addition reaction: a facile approach to preparation of Schonberg adduct. J. Electroanal. Chem. 2008, 621:113-116.
36. Nematollahi D., Shayani-Jam H., Alimoradi M., Niroomand S. Electrochemical oxidation of acetaminophen in aqueous solutions: kinetic evaluation of hydrolysis, hydroxylation and dimerization processes. Electrochim. Acta 2009, 54:7407-7415.
37. Teeter J.S., Meyerhoff R.D. Environmental fate and chemistry of raloxifene hydrochloride. Environ. Toxicol. Chem. 2002, 21:729-736.
38. Dong S.J., Che L.G., Xie Y.W. Chemical Modified Electrode 2003, Science Press, Beijing.
39. Gosser D.K. Cyclic voltammetry: simulation and analysis of reaction mechanisms 1993, VCH, New York.
40. Laviron E. General expression of the linear potential sweep voltammogram in the case of diffusionless electrochemical systems. J. Electroanal. Chem. 1979, 101:19-23.
41. Sharp M., Petersson M., Edstrom K. Preliminary determinations of electron transfer kinetics involving ferrocene covalently attached to a platinum surface. J. Electroanal. Chem. 1979, 95:123-130.
42. Riley C.M., Rosanske T.W. Development and Validation of Analytical Methods 1996, Elsevier Science Ltd., New York.
43. Swartz M.E., Krull I.S. Analytical Method Development and Validation 1997, Marcel Dekker, New York.
44. Gumustas M., Ozkan S.A. The role of and the place of method validation in drug analysis using electroanalytical techniques. The Open. Anal. Chem. J. 2011, 5:1-21.
45. Berry I.R., Harpaz D. Validation of Active Pharmaceutical Ingredients 2001, CRC Press, Washington. Second Ed.
46. Hochner-Celnikier D. Pharmacokinetics of raloxifene and its clinical application. Eur. J. Obstet. Gynecol. Reprod. Biol. 1999, 85:23-29.